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increased over time, while other studies look at functioning. As a result, studies differ in the morbidity trends they incorporate.
Second, it is often difficult to link health to the stage of life of the individual. If people are reporting more chronic disease, is that in the period just before the end of life, in which case the additional disease does not encompass many years? Or is the disease occurring in periods of time far from the end of life, in which case it represents many years of poor health? To answer this question, one needs data on quality of life matched to time until death. Most cross-section data sources do not have such a link, however, and thus they need to make assumptions about the disease process to generate lifetime disease-prevalence estimates. These assumptions can have large impacts on the results.
Third, the data samples that tend to be used often focus on a particular subset of the population, for example the non-institutionalized. Since there are changes in the residential location of the elderly population over time, focusing on population subsets can give biased results.
In this paper, we examine the issue of compression of morbidity, addressing these three concerns. Our primary data source is the Medicare Current Beneficiary Survey, or MCBS. We have MCBS data for a representative sample of the entire elderly population between 1991 and 2009. The sample sizes are large, over 10,000 individuals annually. Further, the MCBS data have been linked to death records through 2008, and hence all deaths can be matched.
Importantly, this includes deaths that occur after the person has left the survey. Thus, we can form morbidity measures by time until death for a large, representative share of the elderly population.
We use these data in two ways. First, we examine trends in various measures of morbidity by time until death. We consider a number of different metrics: the presence of disease; whether the person reports ADL or IADL disability; and various summary measure of functioning that draw together 19 different dimensions of health (Cutler and Landrum, 2011) .
We show trends overall and by time until death.
As is well known, the MCBS data from the 1990s and 2000s show a reduction in the share of elderly people who report ADL or IADL limitations (Freedman et al., 2004 (Freedman et al., , 2013 . Our first result is that this reduction in disability is most marked among those with many years until death. Health status in the year or two just prior to death has been relatively constant over time; in contrast, health measured three or more years before death has improved measurably.
We then translate these changes into disability-free life expectancy and disabled life expectancy. We show that disability-free life expectancy is increasing over time, while disabled life expectancy is falling. For a typical person aged 65, life expectancy increased by 0.7 years between 1992 and 2005. Disability-free life expectancy increased by 1.6 years; disabled life expectancy fell by 0.9 years. The reduction in disabled life expectancy and increase in disability-free life expectancy is true for both genders and for non-whites as well as whites.
Hence, morbidity is being compressed into the period just before death.
The paper is structured as follows. We begin in the next section by defining the compression of morbidity and showing how disability and mortality changes jointly affect disability-free and disabled life expectancy. The second section describes the data we use. The third section presents simple trends in health status by time until death. The fourth section calculates disabled and disability-free life expectancy. The last section concludes.
I.

The Compression of Morbidity
The question we wish to examine is whether morbidity has been compressed into the period just before death, or whether it is accounting for a greater part of the life of elderly individuals. While this goal is clear, the empirical implementation needs a more precise definition. We consider two definitions of a compression of morbidity. One definition, dating back to Fries (1980) , is whether the life table is 'rectangularizing' -that is, whether disabled life expectancy is falling over time. A second definition is more modest: the share of remaining life that is non-disabled is increasing over time. Note that in this latter formulation, disabled life expectancy may be increasing as well, just not as rapidly as non-disabled life expectancy.
In situations where only morbidity or mortality is changing, these two measures will always move together. In situations where both mortality and morbidity are changing, however, trends in the two measures of compression of morbidity may be different.
To see this, consider a simple example presented in Table 1 . The first column depicts a person who lives for five years, the first three of which are without disability, and the fourth and fifth are with a disability. To be concrete, suppose that the person has heart disease in the fourth year and develops chronic obstructive pulmonary disease in the fifth, which results in death six months later. The specific diseases do not matter, but as is typical in the data, we reflect disability as occurring progressively over life and generally do not consider recovery.
In forming life tables, people who die during a year are assumed to die halfway through the year. Thus, the baseline life expectancy 1 is 4.5 years, of which the first 3.0 years is disability-free and the latter 1.5 years is disabled. Now imagine that morbidity declines (column 2). To be specific, suppose that because of improved medical treatment of cardiac risk factors, the person does not suffer a coronary event in the fourth year and thus is not disabled in that year. In year 5, however, the person still suffers lung disease and dies. As the last rows show, overall life expectancy is unchanged, but disability-free life expectancy has increased to 4.0 years and disabled life expectancy has fallen to 0.5 years. By either definition above, disability has been compressed into the period before the end of life.
The third column shows the impact of a reduction in mortality. We imagine that the medical system gets better at treating the combination of heart disease and lung disease, and thus the person survives an additional year with both conditions, albeit they are still disabled. Total life expectancy has increased by one year in this example, all of which is associated with disability. Further, the share of life that is disabled has increased. Thus, there is an expansion of disability by either measure. Note that in this example, the person is still better off; it is just that the disabled part of life has increased.
The final column shows a combination of disability reductions (the person does not suffer the coronary event) and mortality reductions (the person survives an additional year with lung disease). Life expectancy has increased by 1 year, relative to the baseline. The increase is entirely in disability-free life; disabled life starts one year later but ends one year later. In this scenario, whether morbidity has been compressed depends on the definition employed: disabled life expectancy has not declined, but a greater share of life is spent in the non-disabled state.
In general, the impact of combined morbidity and mortality changes on disability-free and disabled life expectancy depends on how rapid each change is and when in the course of life it occurs. All of this we need to evaluate empirically.
II.
Medicare Current Beneficiary Data
Our primary data source is the Medicare Current Beneficiary Survey (MCBS). The MCBS, sponsored by the Centers for Medicare and Medicaid Services (CMS), is a nationally representative survey of aged, disabled, and institutionalized Medicare beneficiaries that oversamples the very old (aged 85 or older) and disabled Medicare beneficiaries. Since we are interested in health among the elderly, we restrict our sample to the population aged 65 and older.
A number of surveys have measures of disability in the elderly population (Freedman et al., 2004) , including the National Health Interview Study and the Health and Retirement Study.
Still, the MCBS has a number of advantages relative to these other surveys. First, the sample size is large, about 10,000 to 18,000 people annually. In addition, the MCBS samples people regardless of whether they live in a household or a long-term care facility, or switch between the two during the course of the survey period. Third, the set of health questions is very broad, encompassing health in many domains. Fourth, and most importantly, individuals in the MCBS have been matched to death records. As a result, we can measure death for over 200,000 people, even after they have left the survey window. Death data are available through 2008.
The MCBS started as a longitudinal survey in 1991. In 1992 and 1993, the only supplemental individuals added were to replace people lost to attrition and to account for newly enrolled beneficiaries. Beginning in 1994, the MCBS began a transition to a rotating panel design, with a four year sample inclusion. About one-third of the sample was rotated out in 1994, and new members were included in the sample. The remainder of the original sample was rotated out in subsequent years. We use all interviews that are available for each person from the start of the survey in 1991 through 2009. We ignore the panel structure of the MCBS interviews and treat each survey year as a repeated cross-section that has been linked to mortality information.
The MCBS has two samples: a set of people who were enrolled for the entire year (the Access to Care sample) and a set of ever-enrolled beneficiaries (the Cost and Use sample). The latter differs from the former in including people who die during the year and new additions to the Medicare population. The primary data that we use are from the health status questionnaire administered in the fall survey, which defines the Access to Care sample. We thus use the Access to Care data. We compute time until death from the exact date at which the Access to Care survey was administered to the person.
The MCBS population becomes older and less white over time, as the elderly population changes demographically. We do not want to show trends that are influenced by these demographic changes. We thus adjust survey weights so that the MCBS population in each year matches the population in the year 2000 by age, gender, and race. All of our tabulations are weighted by these adjusted weights. Trends in the distribution of time until death are shown in Figure 1 . The share of the population that is within one year of death is about 5 percent on average. Reflecting the overall reduction in mortality, this share is declining over time (this will be true of the population 1-2 years from death and 2-3 years from death as well). Between 1991 and 2007, the decline is 1 percentage point, or 18 percent. Correspondingly, the share of the population that is 3 or more years from death increased by about 3 percentage points, also shown in figure 1.
The MCBS asks extensive health questions. The first set of health questions are about medical events the person has experienced. These include cardiovascular conditions (heart disease, stroke), diseases of the central nervous system (Alzheimer's disease, Parkinson's disease), musculoskeletal problems (arthritis, broken hip), pulmonary disease, and cancer. For purposes of disability assessment, we divide these diseases into four groups, based on their likely association with death and disability (Lunney et al., 2003) . The first disease is cancer. Once past the acute phase of cancer treatment, people with cancer tend to have reasonably high quality of life until the last few months of life, when health deteriorates markedly. The second group is permanently disabling conditions that get progressively worse. Alzheimer's disease, Parkinson's disease, and pulmonary disease fall into this category. The third group is acute conditions for which recovery is possible but not assured. This includes heart disease, strokes, and hip fractures. Finally, we group diabetes and arthritis as common disabling but generally non-fatal conditions. Table 2 shows the prevalence of these conditions across all years of the survey, the annual percentage point change in the prevalence over time, and the disability rate conditional on having the disease (defined as whether the person reports an ADL or IADL limitation; see below). Non-fatal conditions are the most common. Over half of the elderly population reports a prior diagnosis of arthritis, the prevalence of which is increasing by 0.3 percentage points annually. Nearly one in five elderly people has diabetes. Acute conditions for which recovery is possible are next most common, ranging in prevalence from 4 percent of the population (hip fracture) to 26 percent (ischemic heart disease). Perhaps owing to better prevention, the prevalence of both heart disease and heart attacks is declining over time. About 18 percent of the elderly population has a history of cancer, which is increasing over time. Degenerative diseases are relatively less common, though pulmonary disease affects about one-seventh of the elderly population. People with these conditions are extremely likely to report having an ADL or IADL impairment.
The MCBS also asks a number of questions about the impact of morbidity on a respondent's ability to function and perform basic tasks, shown in Table 3 . The first category of questions is about physical functioning, such as difficulty walking a reasonable distance (1/4 mile or 2-3 blocks) or carrying moderate-weight objects. Difficulty in these areas ranges from one-quarter to three-quarters of the elderly population. To adjust for this, we create a counterfactual time series for difficulty with vision and hearing assuming that the trend in each variable in the year the survey changed was the same as the trend in the prior three years. We then extend this aggregate estimate back to 1991. At the individual level, we randomly choose individuals who reported that they had a little trouble seeing or hearing and recategorize their responses to having no trouble, to match the adjusted aggregate totals. With these adjustments, about one-third of the elderly population reports vision and hearing impairments on average.
The health status questions are generally the same for the community population and the institutional population, with the exception that the institutionalized are not asked about three IADLs limitations -light housework, preparing meals, and heavy lifting. On average, 5 percent of people are in a nursing home. In order to utilize these questions, we assume that everyone in a nursing home has difficulty with these activities.
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Summary Health Status Measures
The most common single measure of disability in the literature is any difficulty with ADL or IADLs. We follow this in our analysis and define "disability" as an ADL or IADL impairment.
While simple to implement, this measure lacks a rigorous theoretical foundation.
Moreover, a binary measure does not capture heterogeneity in the population. For many purposes, we care about finer gradations in the distribution of health. There is a literature (e.g. Verbrugge and Jette, 1994) arguing for a distinction between functional status (measures of specific physical functioning) and disability (the ability to engage in the activities typically expected of a person). Within this latter spirit, we examine the different dimensions of health among the elderly. In particular, we estimate a factor analytic model of the different domains of functioning and choose the number of domains that best summarize the data.
Formally, denote y ij as the response to question j for individual i. Suppose there are J questions total (J=19 in our setting). We imagine that these health states are a linear function of K different unobserved factors, denoted F ik . We fit a factor analytic model of the form (e.g., Bartholomew, 1987; and Knol and Berger, 1991) :
where y ij is a 0 or 1 outcome variable, γ 0j is a threshold parameter that accounts for varying prevalence of limitations in the population (for example, limitations climbing stairs are more common that limitations in bathing) and the γ kj 's are factor loadings that describe the relationship between unobserved factor k and question j. Unobserved factors are assumed to follow a multivariate normal distribution. The latent variable model described by (1) is similar to the factor analyses and Grade of Membership models that have been previously used to describe dimensions of disability (Lamb, 1996; Manton et al., 1994 Manton et al., , 1998 Woodbury et al., 1978) .
We can fit this model provided K<J. Empirically, because the data tend to be highly correlated and we have 19 dimensions of health, a small number of factors is associated with a wide range of variation in the data. Table 4 shows the results of the factor analysis over the 1991-2009 time period. By the usual criterion of eigenvalues greater than 1, there are three significant factors. Together, these three account for 57 percent of the cumulative variation in the data. These three also have natural economic and demographic interpretations. We thus work with those three.
The predicted factor scores are positively correlated. Prior to rotation, the correlation between factors 1 and 2 is .501, between 1 and 3 is .246, and between 2 and 3 is .265. To aid in interpretation, we consider rotations of the factors that reduce the correlation between them.
Specifically, we use an oblique rotation of the three factor scores (promax=3).
Figure 2 shows a radar plot of the (rotated) factor scores. The first factor loads heavily on ADL and IADL limitations, including bathing, dressing, eating, managing money, and preparing meals. This is a very severely impaired population. The second factor is largely associated with functional limitations and related IADLs, including difficulty walking, lifting, stooping, reading, and doing heavy housework. This group is generally somewhat less impaired.
The third factor is concentrated in sensory impairments, including both vision and hearing.
III. Trends in Health
Our goal is to examine health trends by time until death. We start with overall health trends in the population as a whole and then proceed to trends for the different subgroups by time until death.
Disease prevalence
Disease prevalence is a first measure of health that we consider. Figure 3 shows We consider the major diseases as a group, since they are likely to have the biggest impact on health. Figure 4 shows the prevalence of any major disease by time until death. Since this figure is used repeatedly in the paper, we describe it here in some detail. The second-to-thelowest line of the figure is the overall prevalence of major conditions, analogous to the line in percent of this population, as does Alzheimer's disease and pulmonary disease (chronic degenerative diseases) and heart attacks and stroke (recoverable acute conditions). Parkinson's disease has lower prevalence (4%), as does hip fracture (9%).
The lines just below the top line are the prevalence rate for people 12-24 months from death and 24-36 months from death. For each line, we are restricted to data ending one year earlier, reflecting the fact that the mortality information is only available through 2008. The prevalence of major disease is slightly lower for these groups, but still high. In each case, the prevalence is 70-80 percent. As with the population within 12 months of death, major disease prevalence is not changing in the population 1-2 years and 2-3 years from death. The lowest line in the figure is the prevalence of major disease in people 36 or more months from death. This share is about 50 percent, and is flat after a rise and fall in the early to mid-1990s. Figure 4 shows clearly that not only is major disease prevalence overall unchanged, but major disease prevalence is unchanged in each window of time until death. We return to lifetime disease-free years below.
The prevalence of minor diseases by time until death is shown in figure 5 . There are five lines in the figure, but they are virtually indistinguishable. About 60-70 percent of elderly people have arthritis or diabetes, and that is independent of how close or far they are from death.
Similarly, the prevalence of minor diseases increases over the 2000s for all groups.
Functional Limitations and Disability
We now proceed to functional limitations and ADL/IADL limitations, the latter of which is the most common metric of disability in the literature. 
where i denotes individuals and t denotes the time period (1991-93 or 2004-06) . Demographics include five year age-sex dummy variables, a dummy variable for non-whites, a dummy variable for being married, and a dummy variable for having a high school degree or more. The clinical covariates include dummy variables for the conditions in table 2. Both the demographic and clinical covariates are strongly associated with disability (Table 5 ). Older age is associated with higher disability, as being non-white, being single, and having less education. All of the clinical covariates are associated with higher disability rates, as we would expect.
We then perform a Oaxaca decomposition to understand how much of the reduction in disability can be explained by changes in the X's (for example, the population becoming better educated or less likely to have heart disease) versus changes in the impact of each demographic and clinical factor on disability. We do this in as in equation (3) The next rows show that the bulk of the impact comes from changes in the severity of demographic and clinical risk factors. Conditions have become less disabling over time (see Table 5 ) -especially heart disease and arthritis -and this lowers disability by 2.9 percentage points. Older age is a less disabling than formerly, even given the clinical conditions we measure. This accounts for another 2.1 percentage points. Finally, the constant term, reflecting other factors not captured, shows a large decline in disability. The finding that conditions are less severely disabling than they were formerly motivates our focus on their relation to time until death, not on the incidence of conditions themselves. Figure 7 shows the share of the population with an ADL or IADL limitation by time until death. Since disability defined in this way is the most common health metric in the literature, and it has fallen so much, this figure is in many ways the most crucial to understand population changes in health. Also for this reason, we decompose the change in disability by more periods of time: <12 months until death, 12-24 months until death, 25-48 months until death, 49-72 months until death, 73-96 months until death, and 97+ months until death. Figure 7 shows clearly that the vast bulk of the reduction in disability is among people a few years away from death. Disability is high and has remained so for people within one year of death; about 80 percent of this population is disabled, and that has not changed over time. Indeed, more detailed analysis shows just how sick this population is. The average person in the last 12 months of life has 2.7 ADL limitations and 3.1 IADL limitations. Disability has declined marginally for those 12-24 months from death (2.8 percentage points over the period). Rather, the larger decline is for the population 25 or more months from death. Starting in the group 3 to 4 years from death, disability declines by 6 to 7 percentage points in each group. 4 We can show the implications of these trends using a more formal analysis. Note that the average disability in the population can be expressed as the average of disability for people with different times until death, weighted by the share of people in that time-until-death category:
Disability t = Σ k Share kt * Disability kt , where k references the buckets of time until death. Then, the change in the disability rate is approximately equal to the change in the mortality rates, weighted by initial disability rates, and the change in disability rates, weighted by the population share with that time to live:
ΔDisability ≈ Σ k ΔShare k Disability kto + Σ k Share kto ΔDisability k (4) Table 7 shows the results of this decomposition. As the first row of the second column 
Summary Measures of Health
We finally turn to our three summary measures of health, the factor scores from the factor analysis. We denote them F1, F2, and F3, corresponding to the three largest eigenvalues in Table 3 . We also identify them by the health measures that load on them most strongly: ADL and IADL limitations for F1, functional limitations for F2, and sensory impairments for F3. As is customary, we normalize each factor score to have a mean of 0 and a standard deviation of 1.
A higher score indicates more 'yes' answers to the impairments, and thus a greater level of sickness. Figure 9 shows the trend in the three factor scores. All three decline over time. The greatest decline is for F3, the factor reflecting sensory impairments. The overall decline is approximately one-sixth of a standard deviation. F1, corresponding to ADL and IADL limitations declines the second largest, and F2, corresponding to functional limitations and related ADL and IADL limitations, declines the least.
Figures 10a, b, and c show the changes for each factor score by time until death. Not surprisingly, there is enormous spread in the data. For those within 12 months of death, the average F1 score is about 1.5, the average F2 score is about 0.8, and the average F3 score is about 0.5. These decline somewhat as death moves away in time, but they remain high even for people 24-36 months from death. For that group, F1 and F2 are about 0.5.
Mirroring our results in the binary disability measure, the improvement in these health measures is particularly marked for those farther from death. Except for F3, these summary measures do not improve greatly for those in the 3 years prior to death. Rather, the vast bulk of the decline is in those with three of more years to live until dying. Sensory impairments, however, are declining in all groups, even those very close to death.
Summary
There are many measures of health, not all of which move in the same direction. As a result, there is no single conclusion we can draw. But there are some common trends which are important. Our major conclusion is that time spent in poor physical functioning is being increasingly compressed into the period just before death. Limitations in very severe impairments such as ADLs or IADLs are falling for those not near the end of life, as are more severe functional limitations. Less severe functional limitations are constant, and overall disease prevalence is rising. People have more diseases than they used to, but the severe disablement that disease used to imply has been reduced.
The compression of morbidity into the period just before death means that disability-free life expectancy will be increasing. We explore changes in disability-free and disabled life expectancy quantitatively in the next section.
IV. Disability-Adjusted Life Expectancy
Understanding the compression of morbidity is best done in the context of disabilityadjusted survival. In this section, we turn our estimates of health changes into changes in disabled and disability-free lifeyears. The starting point for our analysis is the standard measure of life expectancy: 
Starting at age a, every (probabilistic) year that the average person survives adds one year to life expectancy. A person who dies in a year is assumed to live half the year, and thus adds half that amount to life expectancy.
Mortality is calculated by the National Center for Health Statistics and routinely published in the National Vital Statistics Reports. We use their data for mortality.
To account for disability, we modify equation (5). For those in the last year of life, we weight the half-year they expect to live by the share of the people in that half year who are not disabled. As Figure 8 shows, this is on average 20 percent. Similarly, we weight the years lived by those one year away from death, two years away from death, three years away from death, and more than three years away from death by the share of population in those intervals who are not disabled. Adding this up over all future ages yields disability-free life expectancy. Disabled life expectancy is the difference between total life expectancy and disability-free life expectancy.
We can form disability-free life expectancy and disabled life expectancy for any year in which we have mortality and disability data. To match our results above, we estimate these Relative to our earlier calculations, we make one additional refinement. Where earlier we showed disability rates on an age-adjusted basis, here we need to disaggregate disability by age. For example, about 45 percent of people who are 36 or more months from death in 1991-93
have an ADL or IADL impairment. But that share is about 30 percent for the youngest elderly and 80 percent for the oldest elderly. To account for this, we form an estimate of disability rates that is age-specific. Rather than calculating means across single-year age by time-until-death cells, which would involve many small cells, we instead use regression analysis to smooth disability rates by age, and other demographic characteristics.
Specifically, we estimate a logistic regression model relating disability to age and its square, a dummy for females, and a dummy for non-white. We estimate this regression separately for 1991-93 and 2004-06 and for each category of time until death: <12 months, 12-24 months, 24-36 months, and 36 months or more. We then predict the disability rates for each person and average the predictions across the relevant groups (e.g., single year of age). We match these to life tables in 1992 and 2005.
Results
We start with basic life expectancy calculations. Figure 11 shows the trend in life expectancy at age 65, separately for men and women. Life expectancy is rising for both groups, but the increase is much greater for men than women. Between 1992 and 2005, life expectancy for a 65 year-old male increased by 1.5 years, while life expectancy for a 65 year-old woman increased by 0.4 years. Our life expectancy data differs from these calculations slightly, since the NCHS does not publish mortality tables beyond age 100. We thus assume everyone dies at that age. Effectively, this reduces our life expectancy increase by 0.2 years. Figure 12 shows the trend in total life expectancy, disability-free life expectancy, and disabled life expectancy for the overall population at age 65. Table 8 shows specific numerical results. Life expectancy at age 65 was 17.5 years in 1992. Reflecting the fact that about half the elderly population is disabled, about half of those years were disabled.
Life expectancy increased by 0.7 years between 1992 and 2005. Because the fall in disability was so large, however, the increase in disability-free life expectancy was greater than the total increase in life expectancy -1.6 years in total. The residual was a reduction in disabled life expectancy of 0.9 years. Thus, both the metric of the change in disabled life expectancy as well as the share of life that is spent disability-free, morbidity is being compressed into the time period just before death. Figure 13 shows life expectancy, disability-free life expectancy, and disabled life expectancy by gender and race. In all four cases, the results are similar: overall life expectancy increased, and disability-free life expectancy increased by even more. As a result, disabled life expectancy fell in all cases. The decline in disabled life expectancy was greater for women than for men, but was similar by race.
In principle, we can estimate changes in life expectancy and disability-free life expectancy by education as well. In practice, while data on mortality by education are collected (since 1989), they are not routinely published.
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We are working to obtain the relevant life tables for the appropriate years from NCHS and will add life expectancy by education when we have done so.
Since so much of the literature has focused on disease-free survival, we have estimated disease-free survival trends as well. We focus on the major diseases in Table 2 , since they are the most consequential for health. Figure 14 shows the results. Disease-free survival increased over time, but so did life expectancy with disease. Of the total increase in life expectancy of 0.7 years, 0.6 years was associated with disease-free survival and 0.1 years was associated with additional life with major disease. The conclusion about the compression of morbidity thus depends on the definition used: the share of life that is disease-free rose, but the length of life with major disease increased as well.
V.
Conclusion
Our results show clearly that over the 1991-2009 period, disability has been compressed into the period just before death. Disability-free life expectancy rose, and disabled life expectancy declined. Thus, by either measure of compression of morbidity, morbidity is being compressed into the period just before death. Disease-free survival increased as well, although so did survival with a major disease.
The major question raised by our results is why this has occurred. How much of this trend is a result of medical care versus other social and environmental factors? Our results do not speak to this issue, but they give us a metric for analyzing the impact of changes that have occurred. We and others could usefully pursue the question about causality in subsequent research. The table is a decomposition of changes in the measure of health indicated in the columns. For each health measure, we estimate equations of the form: H it = X it β t + ε it , for two time periods: 1991-93 and 2004-06. The first row, total change, shows the percentage point change in H it over time. The remaining rows show the predicted percentage point change in H it resulting from changes in the X variables, decomposed into demographics and condition prevalence, and changes in the β's, decomposed into those for conditions, those for demographics, and the constant term. The first column shows the percent change in disability rate for people in each category of time until death. The change is taken from 1991-93 to the latest 3 years available. The second column decomposes the total change in disability. The first row, total change, shows the percentage point change in disability over time from 1991-93 to 1998-00. The second row shows the change in disability resulting from changes in the share of people with different periods of time until death. The remaining shows show the change in disability resulting from changes in the disability rate in each time-until-death category. 
